167 related articles for article (PubMed ID: 24673482)
1. Extended storage of buffy coat platelet concentrates in plasma or a platelet additive solution.
Slichter SJ; Bolgiano D; Corson J; Jones MK; Christoffel T; Bailey SL; Pellham E
Transfusion; 2014 Sep; 54(9):2283-91. PubMed ID: 24673482
[TBL] [Abstract][Full Text] [Related]
2. Extended storage of platelet-rich plasma-prepared platelet concentrates in plasma or Plasmalyte.
Slichter SJ; Bolgiano D; Corson J; Jones MK; Christoffel T
Transfusion; 2010 Oct; 50(10):2199-209. PubMed ID: 20456703
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial comparing autologous radiolabeled in vivo platelet (PLT) recoveries and survivals of 7-day-stored PLT-rich plasma and buffy coat PLTs from the same subjects.
Dumont LJ; Dumont DF; Unger ZM; Siegel A; Szczepiorkowski ZM; Corson JS; Jones MK; Christoffel T; Pellham E; Bailey SL; Slichter SJ;
Transfusion; 2011 Jun; 51(6):1241-8. PubMed ID: 21214584
[TBL] [Abstract][Full Text] [Related]
4. Platelet concentrates prepared after a 20- to 24-hour hold of the whole blood at 22°C.
Slichter SJ; Corson J; Jones MK; Christoffel T; Pellham E; Bolgiano D
Transfusion; 2012 Sep; 52(9):2043-8. PubMed ID: 22320682
[TBL] [Abstract][Full Text] [Related]
5. Platelets stored in whole blood at 4°C: in vivo posttransfusion platelet recoveries and survivals and in vitro hemostatic function.
Slichter SJ; Fitzpatrick L; Osborne B; Christoffel T; Gettinger I; Pellham E; Bailey SL; Jones MK; Herzig MC; Cap AP
Transfusion; 2019 Jun; 59(6):2084-2092. PubMed ID: 30977914
[TBL] [Abstract][Full Text] [Related]
6. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
[TBL] [Abstract][Full Text] [Related]
7. Effects of pretransfusion warming of platelets to 35 degrees C on posttransfusion platelet viability.
Slichter SJ; Christoffel T; Corson J; Jones MK; Pellham E; Bolgiano D
Transfusion; 2009 Nov; 49(11):2319-25. PubMed ID: 19624609
[TBL] [Abstract][Full Text] [Related]
8. Viability and function of 8-day-stored apheresis platelets.
Slichter SJ; Bolgiano D; Jones MK; Christoffel T; Corson J; Rose L; Foley J; Popovsky M; Baril LL; Corda T; Dincecco DM; Snyder EL
Transfusion; 2006 Oct; 46(10):1763-9. PubMed ID: 17002633
[TBL] [Abstract][Full Text] [Related]
9. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
Sandgren P; Callaert M; Shanwell A; Gulliksson H
Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
[TBL] [Abstract][Full Text] [Related]
10. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
[TBL] [Abstract][Full Text] [Related]
11. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat-derived platelet concentrates.
Paglia G; Sigurjónsson ÓE; Rolfsson Ó; Hansen MB; Brynjólfsson S; Gudmundsson S; Palsson BO
Transfusion; 2015 Feb; 55(2):301-13. PubMed ID: 25156572
[TBL] [Abstract][Full Text] [Related]
13. In vivo viability of extended 4°C-stored autologous apheresis platelets.
Stolla M; Fitzpatrick L; Gettinger I; Bailey SL; Pellham E; Christoffel T; Slichter SJ
Transfusion; 2018 Oct; 58(10):2407-2413. PubMed ID: 30203458
[TBL] [Abstract][Full Text] [Related]
14. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
[TBL] [Abstract][Full Text] [Related]
15. Overnight or fresh buffy coat-derived platelet concentrates prepared with various platelet pooling systems.
Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
Transfusion; 2008 Apr; 48(4):723-30. PubMed ID: 18208415
[TBL] [Abstract][Full Text] [Related]
16. In vitro variables of buffy coat-derived platelet concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions.
Gravemann U; Volgmann T; Min K; Philipp R; Lambrecht B; Müller TH; Seltsam A
Transfusion; 2015 Jul; 55(7):1700-9. PubMed ID: 25677807
[TBL] [Abstract][Full Text] [Related]
17. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
Skripchenko A; Kurtz J; Moroff G; Wagner SJ
Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic markers are increased in platelets stored at 37 degrees C.
Bertino AM; Qi XQ; Li J; Xia Y; Kuter DJ
Transfusion; 2003 Jul; 43(7):857-66. PubMed ID: 12823744
[TBL] [Abstract][Full Text] [Related]
19. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the advantages of platelet concentrates stored at 4°C versus 22°C.
Yang J; Yin W; Zhang Y; Sun Y; Ma T; Gu S; Gao Y; Zhang X; Yuan J; Wang W
Transfusion; 2018 Mar; 58(3):736-747. PubMed ID: 29266276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
